The comparison of cervical vestibular evoked myogenic potential (cVEMP) between definite Meniereâ€™s disease(MD) patient and normal subjects

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180521001

Enrollment

Registered

2018-05-21

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To assess saccular function in definite Meniereâ€™s patients by cervical vestibular evoked myogenic potential (cVEMP) cVEMP meniere disease

Interventions

electrode measurement equipment to assess saccular function by test vetibulospinal tract at 1 patient were placing record 5 electrode &#45

ground electrode at forehead &#44

&#45

4 recording electrode at neck muscle 2 electrode for each sides one at mid sternocleidomastoid muscle and for recording electrode and near sternal head of sternocleidomastoid muscle for reference 2 so

n23 latency&#44

p13&#45

n23 amplitude and automatically calculate the amplitude asymmetry ratio for each test

Active Comparator Procedure/Surgery

cVEMP

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Control group 1.no underlying diseade or dizzy or vetigo symptoms 2.E.N.T examination was noral 3 normal hearing in audiogram experimental group Unilateral MD patients as the clinical criteria AAO-HNS 2015 which include A. Two or more spontaneous episodes of vertigo, each lasting 20 minutes to 12 hours( B. Audiometrically documented low to medium frequency sensorineural hearing loss in one ear, defining the affected ear on at least one occasion before, during or after one of the episodesof vertigo C. Fluctuating aural symptoms (hearing, tinnitus or fullness) in the affected ear( D. Not better accounted for by another vestibular diagnosis

Exclusion criteria

Exclusion criteria: 1 patient with middle ear and external ear disease 2.head and neck surgery or problem with c spine and neck muscle which impacted ROM of neck eg, torticolis 3.using relaxant medication eg, mydocalm ,ketamine, Mydocalm anticonvulsant eg Ketamine, Prochlorperazine, Haloperidol, Chlorpromazine 4. pregnancy or on cardiacpacemaker

Design outcomes

Primary

Measure	Time frame
p13 latency,n23 latency,p13-n23 amplitude ,amplitude asymmetry ratio After enrollment patient cVEMP measurement	—

Secondary

Measure	Time frame
no no no	—

Countries

thailand

Contacts

Public Contactjuthaporn plyjun

chulalongkorn Memorial Hospital

alpha_alohaz@hotmail.com0835451188

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026